Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
donald trump
5
×
indiana blog main
indiana top stories
life sciences
medicare
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
5
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
car-t
celgene
democrats
fda
novartis
scott gottlieb
approval
biogen
cancer
clinical study
crispr
What
bio
drugs
house
plan
price
roundup
unveiled
afternoon
airport
allogene
annual
answer
anticipated
apocalypse
awaited
away
becker
beds
billions
blueprint
cancer
celgene
cost
crispr
cut
days
democratic
dems
details
discontent
diversity
dollars
drug
eaton
election
fallout
gene
gone
healthcare
high
Language
unset
Current search:
medicare
×
" donald trump "
×
" raleigh-durham top stories "
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details